APA (7th ed.) Citation

Liu, Y., Ye, J., Ma, J., & Pan, X. (2025). Multicenter validation of CEACAM6 and FOXP3 as robust prognostic biomarkers in colon cancer: Combined immunohistochemical and transcriptomic analysis. Molecular & Clinical Oncology, 23(6), N.PAG. https://doi.org/10.3892/mco.2025.2897

Chicago Style (17th ed.) Citation

Liu, Yingying, Jianxin Ye, Jinzhao Ma, and Xingxiao Pan. "Multicenter Validation of CEACAM6 and FOXP3 as Robust Prognostic Biomarkers in Colon Cancer: Combined Immunohistochemical and Transcriptomic Analysis." Molecular & Clinical Oncology 23, no. 6 (2025): N.PAG. https://doi.org/10.3892/mco.2025.2897.

MLA (9th ed.) Citation

Liu, Yingying, et al. "Multicenter Validation of CEACAM6 and FOXP3 as Robust Prognostic Biomarkers in Colon Cancer: Combined Immunohistochemical and Transcriptomic Analysis." Molecular & Clinical Oncology, vol. 23, no. 6, 2025, p. N.PAG, https://doi.org/10.3892/mco.2025.2897.